Exosome Diagnostics, Inc. has entered into an agreement with Amgen to evaluate the potential to advance drug development with Exosome's proprietary liquid biopsy diagnostics technology and platform.
Cambridge, MA - Exosome Diagnostics, Inc. has entered into an agreement with Amgen to evaluate the potential to advance drug development with Exosome' ...
Satisfied Users & 
Approved Press Releases
